RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Andrew Taylor to Receptors, Interleukin-6

Back to Details
This is a "connection" page, showing publications Andrew Taylor has written about Receptors, Interleukin-6.
Andrew Taylor
Connection Strength
0.150
Receptors, Interleukin-6
  1. Haraoui B, Casado G, Czirj?k L, Taylor A, Bernasconi C, Reiss W, Caporali R. Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies. Clin Exp Rheumatol. 2017 Nov-Dec; 35(6):899-906.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support